FAQS

Know the Facts about Osteoarthritis (OA) of the Knee

Frequently Asked Questions 

Is ORTHOVISC® or MONOVISC® right for me?
If knee pain is keeping you from doing what you love and you've tried other treatments (otc and prescription pain relievers, exercise, physical therapy, corticosteroid injections) and nothing seems to work or is no longer effective, ORTHOVISC® or MONOVISC® may be right for you. only your doctor can determine what treatment may be best for you.

How quickly can I expect pain relief and how long will it last? 
With just a single injection, MONOVISC can provide up to 6 months of knee pain relief.1 Although individual results may vary, some people feel relief immediately after their MONOVISC injection. With just 3-4 consecutive, weekly injections, ORTHOVISC can provide up to 6 months of knee pain relief.1 Everyone responds differently, but some people experience pain relief after the first injection.

Can I receive ORTHOVISC or MONOVISC in my Doctor's office?  
Yes. ORTHOVISC and MONOVISC is given by a trained healthcare professional and can be given in his/her office.

Are there any special treatment instructions?  
If you have any known allergies, you should talk to your doctor to determine if you can take ORTHOVISC or MONOVISC. For the first 48 hours after each injection, it is recommended that you avoid strenuous activities (eg, jogging, tennis, heavy lifting).

Are there any side effects?  
The most commonly reported adverse events are joint pain, back pain and headache. Others include temporary pain at the injection site.  ORTHOVISC should not be given to patients with infections or skin diseases in the area of the injection site. MONOVISC should not be administered to patients with known bleeding disorders.

How often can ORTHOVISC or MONOVISC be injected into my knee?   
The number of courses/injections is a decision you and your doctor need to make. Studies show that retreatment with ORTHOVISC and MONOVISC is safe following the initial 6-month treatment period. Consult your insurance provider to find out about coverage for any retreatments you may receive.

Will my insurance cover ORTHOVISC or MONOVISC?  
Most insurance carriers cover ORTHOVISC and MONOVISC. For more information, call our reimbursement hotline at 1-866-633-VISC(8472).

Myths About Knee Injections 

Myth #1: I worry there are no long lasting relief options for my knee pain. I will just need to learn to live with the pain.

Fact: Learning to live in pain is not an inevitable part of Osteoarthritis (OA) of the knee. Though there is no cure, symptoms can be managed with both nonsurgical and nondrug options. ORTHOISC or MONOVISC High Molecular Weight Hyaluronan, hyaluronic acid injected directly into your knee joint, may provide up to 6 months of knee pain relief. ORTHOVISC or MONOVISC can help you learn to live without your knee pain.

Myth #2: With OA of the knee, I can no longer have an active lifestyle.

Fact: When knee pain is no longer manageable, lifestyle modification often happens because your chosen pain reliever is no longer providing relief. If that is happening to you, make sure your doctor is aware of the pain you are in and how your lifestyle is changing to accommodate it. Ask your doctor if ORTHOVISC or MONOVISC, which may provide up to 6 months of knee pain relief, may be the right treatment choice to provide knee pain relief while allowing you to maintain the activities you enjoy.

Myth #3: I deal with my knee pain daily and I worry about taking too many pain medications.

Fact: ORTHOVISC and MONOVISC is injected into the knee joint, where it acts to replace your natural joint fluid, helping to cushion, protect and lubricate your knee. Studies have shown that ORTHOVISC and MONOVISC can provide pain relief without the use of additional medications which may irritate your stomach or cause cardiovascular complications.

Myth #4: I recently heard about Hyaluronic Acid injections but I thought they are for severe arthritis only.

Fact: FDA-approved Hyaluronic Acid injections were clinically tested on patients suffering from mild-to-moderate OA of the knee. Clinical data shows that OA patients who are treated earlier with Hyaluronic Acid injections can delay total joint replacement surgery for over 2.6 years 1 . Therefore, if you are not clinically, physically, emotionally or financially ready for a total joint replacement, ask your doctor if ORTHOVISC or MONOVISC is the right choice to relieve your knee pain.

 

References
  • 1. Abbott, T; Altman, R; Dimeff, R; Fredericson, M; Vad, V; Vitanzo, P; Yadalam, S; Levine, R; Bisson, B; Bhattacharyya, S. Do Hyaluronic Acid Injections Delay Total Knee Replacement Surgery? Abstract: Poster presented October 29, 2013 at ACR/AHRP Annual Meeting, San Diego, CA
  • ORTHOVISC manufacturers full prescribing information

DSUS/JRC/0914/0475(1) 10/2016

Find a doctor near you

Find A Doctor  

IMPORTANT SAFETY INFORMATION

High Molecular Weight Hyaluronan is indicated in the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. In clinical studies, the most commonly reported adverse events for ORTHOVISC® High Molecular Weight Hyaluronan were arthralgia, back pain, and headache. Other side effects included local injection site adverse events. In clinical studies, the most commonly reported adverse events for MONOVISC® High Molecular Weight Hyaluronan were arthralgia, joint swelling and injection site pain.

ORTHOVISC® and MONOVISC® High Molecular Weight Hyaluronan are contraindicated in patients with known hypersensitivity to hyaluronate formulations or known hypersensitivity (allergy) to gram positive bacterial proteins. ORTHOVISC® and MONOVISC® High Molecular Weight Hyaluronan should not be injected in patients with infections or skin diseases in the area of the injection site or joint. MONOVISC® High Molecular Weight Hyaluronan should not be administered to patients with known bleeding disorders. Intra-articular injection of sodium hyaluronate preparations has occasionally been associated with allergic/anaphylactic reactions and transient hypotension, which have generally resolved spontaneously or after conservative treatment.